ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,307.01
      -0.27%
      US Tech 100
      18,183.20
      -0.27%
      Dow Jones
      39,671.04
      -0.51%
      Brent Oil
      81.495
      -1.15%
      Bitcoin
      69,765.54
      -0.52%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sanofi (GCVRZ)

      7. Sanofi (GCVRZ) News

      GCVRZ

      Sanofi (GCVRZ)

      Sanofi
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GCVRZ
      DateTimeSourceHeadlineSymbolCompany
      02/04/20148:32AMBusiness WireGlancy Binkow & Goldberg Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit on Behalf of Investors ...NASDAQ:GCVRZSanofi
      01/28/20141:31PMBusiness WireSANOFI CONTINGENT VALUE RIGHTS SHAREHOLDERS: The Alexander Firm P.C. Announces Upcoming Lead Plaintiff Deadline in Class Acti...NASDAQ:GCVRZSanofi
      01/24/20145:35PMPR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Sanofi Pharmaceuticals, Inc. and Certain Officers - G...NASDAQ:GCVRZSanofi
      01/17/20149:32PMBusiness WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit on Behalf of Investors of Sanofi Contingent Value RightsNASDAQ:GCVRZSanofi
      01/17/20149:00AMBusiness WireLieff Cabraser Reminds Sanofi Investors of Upcoming Deadline in Class Action Litigation – GCVRZNASDAQ:GCVRZSanofi
      01/06/20145:50PMBusiness WireSHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Sanofi to Contact B...NASDAQ:GCVRZSanofi
      12/20/20139:00AMBusiness WireLieff Cabraser Announces Class Action Litigation Against Sanofi, Inc. - GCVRZNASDAQ:GCVRZSanofi
      12/19/201311:12AMBusiness WireSHAREHOLDER ALERT: Investors in Sanofi Contingent Value Rights Are Encouraged To Contact Wolf HaldensteinNASDAQ:GCVRZSanofi
      11/19/20135:02PMBusiness WireGlancy Binkow & Goldberg LLP Announces Investigation of SanofiNASDAQ:GCVRZSanofi
      04/05/20118:15AMZacksGenzyme in Sanofi's Control - Analyst BlogNASDAQ:GCVRZSanofi
       Showing the most relevant articles for your search:NASDAQ:GCVRZ